Newsroom

Sorted by: Latest

-

KAON Broadband Showcases Field-Proven prpl Deployments and Wi-Fi 8-Ready Platforms at prpl Summit 2026

VIENNA--(BUSINESS WIRE)--The prpl Foundation highlighted KAON Broadband’s participation in the prpl Summit 2026 as an Innovation Partner for Technical Day and a Technology Partner for Business Day. This partnership underscores KAON Broadband’s continued commitment to advancing open-source broadband platforms, backed by its extensive experience in commercial operator deployments and ongoing development of next-generation connectivity solutions. KAON Broadband has played an active role in bringin...
-

The Chemours Company Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CC

LOS ANGELES--(BUSINESS WIRE)--The Chemours Company Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CC...
-

Netcapital Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NCPL

LOS ANGELES--(BUSINESS WIRE)--Netcapital Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NCPL...
-

GoodVision AI to Showcase AI Inference Infrastructure at TechCrunch Disrupt 2026

REDWOOD CITY, Calif.--(BUSINESS WIRE)--GoodVision AI (“GoodVision”), a developer of next-generation AI compute infrastructure purpose-built for inference, today announced that it will exhibit at TechCrunch Disrupt 2026, taking place October 13–15, 2026, at Moscone West in San Francisco. The appearance follows the September 11 approval of GoodVision’s business combination with Calisa Acquisition Corp. (Nasdaq: ALIS), marking a new stage in the company’s development as it expands its AI inference...
-

Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of one-year results from the pivotal Phase 2b/3 BRUNELLO trial evaluating remigromig (MK-3000, formerly EYE103), an investigational, potentially first-in-class tetravalent, tri-specific antibody designed to activate the Wingless-related integration site (Wnt) pathway, for the treatment of diabetic macular edema (DME). Results were presented today at the...
-

Genentech Presents New Phase III One-Year Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today new one-year data from the Phase III MEERKAT and SANDCAT studies evaluating investigational vamikibart compared with a sham procedure that mimics intravitreal (IVT) injections in adults with uveitic macular edema (UME). Across both studies, data continue to support the potential for rapid and sustained improvements in vision and reductions in macular thickness (swel...
-

AXP Investors with $100,000 in Losses Have Opportunity to Join American Express Company Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--AXP Investors with $100,000 in Losses Have Opportunity to Join American Express Company Fraud Investigation with SBS Law...
-

ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES--(BUSINESS WIRE)--ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law...
-

T-Mobile Crews and Teams Restore Connectivity as Gulf Coast Communities Recover from Hurricane Isaias

BELLEVUE, Wash.--(BUSINESS WIRE)--Across the Gulf Coast, families and communities are facing the aftermath of Hurricane Isaias, including the tragic loss of life, damaged homes, flooding and widespread power outages. Our hearts are with those who have lost loved ones and everyone affected by the storm. At a time when reaching family, checking on neighbors or getting help matters more than ever, staying connected is especially important. Key Updates: Maintaining connectivity and restoring servic...
-

CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law

LOS ANGELES--(BUSINESS WIRE)--CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law...